Related Experiment Videos
Two-chain subunit structure of HLA-D antigens
Tissue Antigens
|October 1, 1977
Summary
Rabbit anti-B-cell antibodies block the mixed lymphocyte culture (MLC) reaction by targeting stimulator cells. These antibodies specifically precipitate leukemia cell membrane antigens, identifying 27,000 and 35,000 dalton subunits.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- The mixed lymphocyte culture (MLC) reaction is a key model for studying T-cell mediated immune responses.
- Identifying specific cell surface antigens involved in immune cell interactions is crucial for understanding immune regulation and disease pathogenesis.
Purpose of the Study:
- To investigate the role of B-cell specific antigens in modulating the mixed lymphocyte culture (MLC) reaction.
- To characterize the B-cell specific membrane antigens recognized by rabbit anti-B-cell antisera.
Main Methods:
- Rabbit anti-B-cell antisera, including F(ab')2 fragments and intact antibodies, were used to assess their effect on the MLC reaction.
- Antisera specificity was confirmed using antibodies against beta2 microglobulin.
- Acute lymphocytic leukemia (ALL) cell membrane antigens were labeled with 125I, solubilized, and immunoprecipitated using anti-B-cell antisera.
Main Results:
- Both F(ab')2 fragments and intact rabbit anti-B-cell antibodies effectively blocked the MLC reaction.
- The blocking activity was attributed to the antisera targeting the stimulator cells, not the responder cells.
- Antisera against beta2 microglobulin did not inhibit the MLC-stimulating cell, confirming the specificity of the B-cell antisera.
- Immunoprecipitation revealed that both human and rabbit anti-B-cell antisera recognized polypeptide subunits of 27,000 and 35,000 daltons from ALL cell membranes.
Conclusions:
- Rabbit anti-B-cell antisera can specifically inhibit the MLC reaction by interacting with stimulator cell surface antigens.
- The identified 27,000 and 35,000 dalton polypeptide subunits represent potential targets for modulating T-cell responses in B-cell related conditions.